EUVIMEDEUVIMED entdecken
Crossref

Multi-drug-resistant tuberculosis and its associated factors among pulmonary tuberculosis patients linked to first-line anti-tuberculosis drugs in north-west Ethiopia

Mulat Erkihun, Teklehaimanot Kiros, Ayenew Berhan, Bayu Ayele

Journal of Medical Microbiology · 15.12.2023 · 72 (12)

DOI: 10.1099/jmm.0.001775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, erschienen am 15.12.2023. Verfasst von Mulat Erkihun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, College of Health Sciences, Debre Tabor, University Debre Tabor, Debre Tabor, Ethiopia. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Multi-drug-resistant tuberculosis (MDR-TB) is an emerging global challenge. Ethiopia is one of the 20 top countries with the highest estimated numbers of incidents of MDR-TB. Recently, the World Health Organization warned that drug-resistant TB is escalating and called for concerted action to reduce the spread of drug resistance. Hypothesis. The current study investigated MDR-TB in patients receiving first-line anti-TB drug treatment and associated factors.

Aim

The study aimed to determine the prevalence of MDR-TB and its associated factors among smear-positive pulmonary TB patients receiving first-line anti-TB drug treatment. Methodology. An institution-based cross-sectional study was employed. All data were collected from laboratory result log books and information via a questionnaire. Samples from 205 smear-positive pulmonary TB patients were selected among first-line drug treatment by a systematic sampling method. Specimens were transported to Felege Hiwot referral hospital laboratory for GeneXpert testing. Factors associated with an outcome variable in binary multi-variable logistic regression analysis at P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantTuberculosis, PulmonaryHumansAntitubercular AgentsEthiopiaCross-Sectional StudiesRifampin

Stichwörter der Autor:innen

multi-drug-resistant tuberculosispulmonary tuberculosissmear-positive

Substanzen

Antitubercular AgentsRifampin

Autor:innen und Institutionen

  • Department of Medical Laboratory Sciences, College of Health Sciences, Debre Tabor, University Debre Tabor, Debre Tabor, Ethiopia.
  • Laboratory Service Unit, Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia.

Zitieren

APA

Erkihun, M., Kiros, T., Berhan, A., & Ayele, B. (2023). Multi-drug-resistant tuberculosis and its associated factors among pulmonary tuberculosis patients linked to first-line anti-tuberculosis drugs in north-west Ethiopia. Journal of Medical Microbiology, 72(12). https://doi.org/10.1099/jmm.0.001775

Vancouver

Erkihun M, Kiros T, Berhan A, Ayele B. Multi-drug-resistant tuberculosis and its associated factors among pulmonary tuberculosis patients linked to first-line anti-tuberculosis drugs in north-west Ethiopia. Journal of Medical Microbiology. 2023;72(12). doi:10.1099/jmm.0.001775

BibTeX
@article{Erkihun2023,
  author = {Erkihun, Mulat and Kiros, Teklehaimanot and Berhan, Ayenew and Ayele, Bayu},
  title = {Multi-drug-resistant tuberculosis and its associated factors among pulmonary tuberculosis patients linked to first-line anti-tuberculosis drugs in north-west Ethiopia},
  journal = {Journal of Medical Microbiology},
  year = {2023},
  volume = {72},
  number = {12},
  doi = {10.1099/jmm.0.001775}
}
Kostenlos starten →